BPI-371153 / Betta Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BPI-371153 / Betta Pharma
NCT05341557: A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Not yet recruiting
1
110
RoW
BPI-371153
Betta Pharmaceuticals Co., Ltd.
Advanced Solid Tumor, Lymphoma, NSCLC, HCC
06/24
06/25

Download Options